Lightbody 1978.
Methods | Crossover design; each phase 3 days. | |
Participants | ||
Interventions | 2 interventions: Ipratropium bromide 40µg and Salbutamol 200µg, q.i.d. | |
Outcomes | ||
Notes | This comparison not analysed, so details not extracted. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment (selection bias) | Unclear risk | Information not available (Cochrane Grade B) |